Salud financiera de hoja de balance de VBI Vaccines
Salud financiera controles de criterios 2/6
VBI Vaccines has a total shareholder equity of $-5.5M and total debt of $48.7M, which brings its debt-to-equity ratio to -891.6%. Its total assets and total liabilities are $75.4M and $80.9M respectively.
Información clave
-891.6%
Ratio deuda-patrimonio
US$48.75m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$12.60m |
| Patrimonio | -US$5.47m |
| Total pasivo | US$80.91m |
| Activos totales | US$75.44m |
Actualizaciones recientes sobre salud financiera
Recent updates
VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook
Sep 22VBI Vaccines gets up to $100M debt funding from K2 HealthVentures
Sep 15Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe
Sep 08VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings
Aug 26VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis
Jun 17Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24Análisis de la situación financiera
Pasivos a corto plazo: VBIV.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: VBIV.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: VBIV.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Reducción de la deuda: VBIV.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: VBIV.Q has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Pronóstico de cash runway: VBIV.Q is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.